Matthew Harkenrider, MD

Dr. Harkenrider is Associate Professor of Radiation Oncology, Medical Director, Residency Program Director, and Director of Brachytherapy at Loyola University Chicago in Chicago, Illinois. He serves on committees within the NCI Gynecologic Cancer Steering Committee and on the ASTRO Guidelines Committee. He serves on the Cervical Cancer and Lung Cancer Core Committees for NRG Oncology and works to develop clinical trials of novel multimodality therapy for the treatment of gynecologic and lung malignancies. He is active within the American Society of Radiation Oncology and American Brachytherapy Society, serving as a faculty member for the ASTRO Annual Meeting, ABS Annual Meeting and the ABS GYN School. Dr. Harkenrider is the Chair of the American College of Radiology HDR Brachytherapy Practice Parameter. He has published numerous peer-reviewed manuscripts with an emphasis on gynecologic brachytherapy and lung stereotactic body radiation therapy. He has also been active within the EMBRACE group and led the effort at Loyola to become the first U.S. institution to open and accrue to the EMBRACE 2 study. He has worked extensively on delivering state-of-the-art treatment for locally advanced cervical cancer patients and developing and promoting MRI-based cervical brachytherapy.

Disclosures:

• Employment: Loyola University Medical Center:Professor of Radiation Oncology:Employee
• Compensation: RTOG Foundation: Consultant, Compensation Payment-End Date: 8/1/2023 ;NEED: Consultant, Compensation Payment-End Date: to present ;Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 11/15/2024
• Ownership: none
• Leadership: none